Yoshida H - Search Results

1

Pyrazolopyridine derivative acts as a novel cyclooxygenase inhibitor: antiplatelet effect in aged patients with ischemic stroke.

Satoh K, Yoshida H, Imaizumi TA, Koyama M, Hiramoto M, Takamatsu S. Satoh K, et al. Among authors: yoshida h. J Am Geriatr Soc. 1994 Jun;42(6):639-42. doi: 10.1111/j.1532-5415.1994.tb06863.x. J Am Geriatr Soc. 1994. PMID: 8201150 Clinical Trial.

2

Platelet-activating factor acetylhydrolase in red cell membranes. Does decreased activity impair erythrocyte deformability in ischemic stroke patients?

Yoshida H, Satoh K, Takamatsu S. Yoshida H, et al. Stroke. 1993 Jan;24(1):14-8. doi: 10.1161/01.str.24.1.14. Stroke. 1993. PMID: 8418541

3

Plasma 11-dehydrothromboxane B2: a reliable indicator of platelet hyperfunction in patients with ischemic stroke.

Satoh K, Imaizumi T, Yoshida H, Hiramoto M, Konta A, Takamatsu S. Satoh K, et al. Among authors: yoshida h. Acta Neurol Scand. 1991 Feb;83(2):99-102. doi: 10.1111/j.1600-0404.1991.tb04657.x. Acta Neurol Scand. 1991. PMID: 2017905

4

Increased levels of blood platelet-activating factor (PAF) and PAF-like lipids in patients with ischemic stroke.

Satoh K, Imaizumi T, Yoshida H, Hiramoto M, Takamatsu S. Satoh K, et al. Among authors: yoshida h. Acta Neurol Scand. 1992 Feb;85(2):122-7. doi: 10.1111/j.1600-0404.1992.tb04010.x. Acta Neurol Scand. 1992. PMID: 1574985

5

Platelet-activating factor acetylhydrolase in plasma lipoproteins from patients with ischemic stroke.

Satoh K, Yoshida H, Imaizumi T, Takamatsu S, Mizuno S. Satoh K, et al. Among authors: yoshida h. Stroke. 1992 Aug;23(8):1090-2. doi: 10.1161/01.str.23.8.1090. Stroke. 1992. PMID: 1636183

6

Increased activity of the platelet-activating factor acetylhydrolase in plasma low density lipoprotein from patients with essential hypertension.

Satoh K, Imaizumi T, Kawamura Y, Yoshida H, Takamatsu S, Takamatsu M. Satoh K, et al. Among authors: yoshida h. Prostaglandins. 1989 Jun;37(6):673-82. doi: 10.1016/0090-6980(89)90104-4. Prostaglandins. 1989. PMID: 2772220

7

Activity of platelet-activating factor (PAF) acetylhydrolase in plasma from patients with ischemic cerebrovascular disease.

Satoh K, Imaizumi T, Kawamura Y, Yoshida H, Takamatsu S, Mizono S, Shoji B, Takamatsu M. Satoh K, et al. Among authors: yoshida h. Prostaglandins. 1988 May;35(5):685-98. doi: 10.1016/0090-6980(88)90142-6. Prostaglandins. 1988. PMID: 3399678

8

Density-associated changes in platelet-activating factor acetylhydrolase activity and membrane fluidity of human erythrocytes.

Yoshida H, Satoh K, Ishida H, Imaizumi T, Koyama M, Hiramoto M, Nakazawa H, Takamatsu S. Yoshida H, et al. Ann Hematol. 1994 Sep;69(3):139-45. doi: 10.1007/BF01695695. Ann Hematol. 1994. PMID: 8086509

9

High-density lipoprotein inhibits the production of platelet activating factor acetylhydrolase by HepG2 cells.

Satoh K, Imaizumi T, Yoshida H, Takamatsu S. Satoh K, et al. Among authors: yoshida h. J Lab Clin Med. 1994 Feb;123(2):225-31. J Lab Clin Med. 1994. PMID: 8301198

10

Effect of 17 beta-estradiol on secretion of platelet-activating factor acetylhydrolase by HepG2 cells.

Satoh K, Imaizumi T, Yoshida H, Takamatsu S. Satoh K, et al. Among authors: yoshida h. Metabolism. 1993 Jun;42(6):672-7. doi: 10.1016/0026-0495(93)90231-c. Metabolism. 1993. PMID: 8510509

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,987 results

Search Page

Filters